ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,285.42
0.38%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.726
0.21%
Brent Oil
84.165
0.26%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Precision BioSciences Inc (DTIL)

  7. Precision BioSciences Inc (DTIL) ニュース

DTIL

Precision BioSciences (DTIL)

Precision BioSciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:DTIL
日付受信時刻ニュースソース見出しコード企業名
2024/05/0909 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0909 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0909 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0909 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0821 : 19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
2024/05/0821 : 15Business WirePrecision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private PlacementNASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 30Business WirePrecision BioSciences to Report First Quarter Results on May 13, 2024NASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0805 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
2024/05/0721 : 30Business WirePrecision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) DeficiencyNASDAQ:DTILPrecision BioSciences Inc
2024/05/0120 : 05Business WirePrecision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024NASDAQ:DTILPrecision BioSciences Inc
2024/04/1705 : 15Business WirePrecision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail TherapeuticsNASDAQ:DTILPrecision BioSciences Inc
2024/03/2719 : 45Business WirePrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business UpdateNASDAQ:DTILPrecision BioSciences Inc
2024/03/2105 : 30Business WirePrecision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024NASDAQ:DTILPrecision BioSciences Inc
2024/03/1920 : 00Business WirePrecision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial MyopathyNASDAQ:DTILPrecision BioSciences Inc
2024/03/0622 : 45Business WirePrecision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC DeficiencyNASDAQ:DTILPrecision BioSciences Inc
2024/03/0122 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
2024/03/0120 : 30Business WirePrecision BioSciences Announces $40.0 Million Offering of Common Stock and WarrantsNASDAQ:DTILPrecision BioSciences Inc
2024/03/0120 : 00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:DTILPrecision BioSciences Inc
2024/03/0107 : 19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DTILPrecision BioSciences Inc
2024/03/0106 : 01Business WirePrecision BioSciences Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:DTILPrecision BioSciences Inc
2024/02/2021 : 00Business WirePrecision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou BiosciencesNASDAQ:DTILPrecision BioSciences Inc
2024/02/1421 : 00Business WirePrecision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical ReadinessNASDAQ:DTILPrecision BioSciences Inc
2024/02/1322 : 29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
2024/02/1321 : 00Business WirePrecision BioSciences Promotes Naresh Tanna to Vice President of Investor RelationsNASDAQ:DTILPrecision BioSciences Inc
2024/02/1301 : 00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DTILPrecision BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:DTIL

最近閲覧した銘柄

NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
FX
USDGBP
US Dollar vs Sterling
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
NYSE
VZ
Verizon Communications
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
CCOM
US500
US 500
COIN
BTCUSD
Bitcoin
NASDAQ
GOOGL
Alphabet
NYSE
NKE
Nike
CCOM
SILVER
SILVER
SPI
SP500
S&P 500
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有